Hospital-acquired fungal pneumoniain children who underwent polychemotherapy
Infectious complications are the leading cause of death in cancer patients. Fungal infection occurs in 20–70 % of patients undergoing chemotherapy with 40 % mortality rate. The efficacy of antifungal agents has been assessed in children undergoing chemotherapy
Main Authors: | A. V. Sotnikov, V. G. Polyakov, A. I. Saltanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2016-02-01
|
Series: | Sibirskij Onkologičeskij Žurnal |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/233 |
Similar Items
-
Study on the Sources of Nosocomial Fungal Infections at Intensive Care Unit and Transplant Wards at a Teaching Hospital in Tehran
by: P Kordbacheh, et al.
Published: (2005-07-01) -
Study on the Sources of Nosocomial Fungal Infections at Intensive Care Unit and Transplant Wards at a Teaching Hospital in Tehran
by: P Kordbacheh, et al.
Published: (2005-06-01) -
EPIDEMIOLOGY ASPECTS OF HOSPITAL-ACQUIRED INFECTION MORBIDITY IN HEALTH SURGERY HOSPITALS IN PRIMORSKY REGION
by: A. V. Martynova, et al.
Published: (2018-01-01) -
APACHE II SCORING SYSTEM AND ITS MODIFICATION FOR THE ASSESSMENT OF DISEASE SEVERITY IN CHILDREN WHO UNDERWENT POLYCHEMOTHERAPY
by: А. V. Sotnikov, et al.
Published: (2016-02-01) -
Clinical significance of the isolation of Candidaspecies from hospitalized patients
by: Yankee C. Magalhães, et al.
Published: (2015-03-01)